• Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP
  • Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP
  • Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP
  • Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP
  • Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP
  • Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP

Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP

Application: Internal Medicine
Usage Mode: IV
Suitable for: Elderly, Adult
State: Liquid
Shape: Injection
Type: Organic Chemicals
Diamond Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company

Basic Info.

Model NO.
100ml
Pharmaceutical Technology
Chemical Synthesis
Ingredient
Metronidazole, Nacl
Standard
USP
Transport Package
PP Bottles in Carton
Specification
100ml: 0.5g;
Origin
P. R. China
HS Code
3004909099
Production Capacity
10 Million Bottles/Year

Product Description

Metronidazole Injection, USP is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with Metronidazole therapy. In a mixed aerobic and anaerobic infection, antibiotics appropriate for the treatment of the aerobic infection should be used in addition to Metronidazole.
Metronidazole is effective in Bacteroides fragilis infections resistant to clindamycin, chloramphenicol and penicillin.
Intra-abdominal Infections, including peritonitis, intra-abdominal abscess and liver abscess, caused by Bacteroides species including the B. fragilis group (B. fragilis, B. distasonis, B. ovatus,B. thetaiotaomicron, B. vulgatus).Clostridium species, Eubacterium species, Peptococcus species, and Peptostreptococcus species.
Skin and Skin Structure Infections caused by Bacteroides species including B. fragilis group, Clostridium species, Peptococcus species, Peptostreptococcus species and Fusobacterium species.
Gynecologic Infections, including endometritis, endomyometritis, tubo-ovarian abscess, and post-surgical vaginal cuff infection, caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcus species and Peptostreptococcus species.
Bacterial Septicemia caused by Bacteroides species including the B. fragilis group and Clostridium species.
Bone and Joint Infections, as adjunctive therapy, caused by Bacteroides species including the B. fragilis group.
Central Nervous System (CNS) Infections, including meningitis and brain abscess, caused by Bacteroides species including the B. fragilis group.
Lower Respiratory Tract Infections, including pneumonia, empyema, and lung abscess, caused by Bacteroides species including the B. fragilis group.
Endocarditis caused by Bacteroides species including the B. fragilis group.
Prophylaxis: The prophylactic administration of Metronidazole Injection, USP preoperatively, intraoperatively, and postoperatively may reduce the incidence of postoperative infection in patients undergoing selective colorectal surgery which is classified as contaminated or potentially contaminated.
Metronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USPMetronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USPMetronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USPMetronidazole Injection Large Volume Intravenous Solution (IV) for Infusion in PP Bottle, USP
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Type of Ownership
Limited Company